Windlas Biotech IPO Detail
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 30 | ₹13,800 |
| Maximum | 14 | 420 | ₹193,200 |
Incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
Competitive strengths
- Strong focus on the chronic therapeutic category.
- Leading market player in the domestic pharmaceutical formulation CDMO segment.
- Professional and experienced Promoters and a senior management team.
- Strong focus on the chronic therapeutic category.
- An innovative product portfolio of complex generic products
Company Promoters:
Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass, and AKW WBL Family Pvt Trust are the company promoters.
| IPO Opening Date | Aug 4, 2021 |
| IPO Closing Date | Aug 6, 2021 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹5 per equity share |
| IPO Price | ₹448 to ₹460 per equity share |
| Market Lot | 30 Shares |
| Min Order Quantity | 30 Shares |
| Listing At | BSE, NSE |
| Issue Size | Eq Shares of ₹5 (aggregating up to ₹401.54 Cr) |
| Fresh Issue | Eq Shares of ₹5 (aggregating up to ₹165.00 Cr) |
| Offer for Sale | 5,142,067 Eq Shares of ₹5 (aggregating up to ₹236.54 Cr) |
| Basis of Allotment Date | Aug 11, 2021 |
| Initiation of Refunds | Aug 12, 2021 |
| Credit of Shares to Demat Account | Aug 13, 2021 |
| IPO Listing Date | Aug 17, 2021 |
Thank You for reading If you like please support, it's free.